Trademark: TERLIVAZ TERLIPRESSIN FOR INJECTION
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
TERLIVAZ TERLIPRESSIN FOR INJECTION
Click here to search for trademarks similar to TERLIVAZ TERLIPRESSIN FOR INJECTION
Proof of use for TERLIVAZ TERLIPRESSIN FOR INJECTION
We do not have any records of a proof of use for TERLIVAZ TERLIPRESSIN FOR INJECTION at this moment.
Click here to add a proof of use for TERLIVAZ TERLIPRESSIN FOR INJECTION
Possible trademark infringements of TERLIVAZ TERLIPRESSIN FOR INJECTION
Basic Information about TERLIVAZ TERLIPRESSIN FOR INJECTION
- Serial Number
- 86532781
- Filing Date
- 12 Feb 2015
- Mark Drawing Code
- 3
Classifications
Declare the trademark use of TERLIVAZ TERLIPRESSIN FOR INJECTION on the blockchain with WikiTrademarks.io.
- First use of TERLIVAZ TERLIPRESSIN FOR INJECTION anywhere
- No first use declared yet.
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 006; 018; 044; 046; 051; 052
Who owns TERLIVAZ TERLIPRESSIN FOR INJECTION?
1. Ikaria Therapeutics LLC Hampton NJ
2. Ikaria Therapeutics LLC Hampton NJ
Correspondent
- ANDREW N. SPIVAK
- MOSAIC LEGAL GROUP, PLLC
- 5185 MACARTHUR BLVD NW STE 350
- WASHINGTON, DC 20016-3353
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io